Total planned funding: $1,227,701,779
Clear active filters
HTXD: Treatment: ARV Drugs
Private Contractor
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $292,763,913 |
Zambia | $185,204,406 |
Mozambique | $106,015,587 |
Côte d'Ivoire | $96,062,838 |
Tanzania | $92,181,640 |
Uganda | $88,919,634 |
Ethiopia | $72,104,781 |
Kenya | $68,268,240 |
Rwanda | $53,135,729 |
Zimbabwe | $34,206,800 |
Haiti | $32,706,817 |
South Africa | $30,033,054 |
Vietnam | $22,934,000 |
Democratic Republic of the Congo | $21,726,094 |
Guyana | $7,676,986 |
Cameroon | $5,609,542 |
Western Hemisphere Region | $4,249,880 |
West Africa Region | $3,560,293 |
Namibia | $3,393,625 |
Botswana | $2,879,131 |
Eswatini | $1,933,169 |
Burundi | $1,052,204 |
Asia Regional Program | $425,000 |
enumerations.Philippines | $358,416 |
Malawi | $300,000 |
Organizational Types
Private Contractor | $1,227,701,779 |
Program Areas
Treatment | $1,227,701,779 |
Budget Codes
HTXD: Treatment: ARV Drugs | $1,227,701,779 |
Top Partner Programs
Chemonics International:
$438,773,361
View countries
John Snow, Inc:
$11,245,804
View countries